Vial

INDIVIDUAL TEST 804

TS-HDS Antibodies (IgM)

Indication

Suspicion of small fiber neuropathy (SFN)

Sample material

Serum

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: room temperature
  • International: cold

Method

ELISA

Reference interval

< 9 U/mL negative

Result

Results are reported as negative or positive with a concentration.

Interpretation

IgM-antibodies against trisulfated heparan disaccharide (TS-HDS) are reported in a subgroup of patients with small fiber neuropathy (SFN).

TS-HDS IgM-antibodies seem more frequent and specific for SFN than IgG-antibodies against fibroblast growth factor receptor 3 (FGFR3).

References

  • Farhad K. Curr Neurol Neurosci Rep. 2019. Current Diagnosis and Treatment of Painful Small Fiber Neuropathy. PMID: 31773305
  • Levine TD et al. Muscle Nerve. 2020. Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3. PMID: 31650561
  • Zeidman LA. Neurol Clin. 2021. Advances in the Management of Small Fiber Neuropathy. PMID: 33223078
  • Morelli L et al. Rev Neurosci. 2024. The role of antibodies in small fiber neuropathy: a review of currently available evidence. PMID: 38865989

Last updated: 2025-10-09

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 804

TS-HDS-antikroppar (IgM)

Indikation

Misstanke om fintrådsneuropati (SFN)

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Transport

  • Inom Sverige: rumstemperatur
  • Internationellt: kylt

Metod

ELISA

Referensintervall

< 9 U/mL negativt

Resultat

Resultat anges som negativt eller positivt med koncentration.

Tolkning

IgM-antikroppar mot trisulfated heparan disaccharide (TS-HDS) har rapporterats förekomma hos en grupp av patienter med fintrådsneuropati (SFN).

TS-HDS IgM-antikroppar förefaller vara vanligare och mer specifika för fintrådsneuropati än IgG-antikroppar mot fibroblast growth factor receptor 3 (FGFR3).

Referenser

  • Farhad K. Curr Neurol Neurosci Rep. 2019. Current Diagnosis and Treatment of Painful Small Fiber Neuropathy. PMID: 31773305
  • Levine TD et al. Muscle Nerve. 2020. Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3. PMID: 31650561
  • Zeidman LA. Neurol Clin. 2021. Advances in the Management of Small Fiber Neuropathy. PMID: 33223078
  • Morelli L et al. Rev Neurosci. 2024. The role of antibodies in small fiber neuropathy: a review of currently available evidence. PMID: 38865989

Senast uppdaterat: 2025-10-09

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi

Hittar du inte vad du söker? Vi kan hjälpa till